SLC7A5 and lung carcinoma: K5/6 has superior sensitivity and reliability in differentiating between benign and malignant prostate glands when compared with K903 (high molecular weight keratins); and [34] it has been used successfully in a five antibody panel (which also targets TRIM29, CEACAM5, SLC7A5, MUC1) to better classify the subtypes of lung carcinoma [44].